| |
|
|
|
|
|
|
|||
|
Blood, 15 June 2006, Vol. 107, No. 12, pp. 4880-4887. Prepublished online as a Blood First Edition Paper on February 23, 2006; DOI 10.1182/blood-2005-08-3423.
NEOPLASIA Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell linesFrom the Department of Molecular Oncology, Graduate School of Medical & Dental Sciences, and Department of Hematology and Immunology, Kagoshima University Hospital, Center for Chronic Viral Diseases, Division of Host Response, Kagoshima University, Sakuragaoka, Japan; and Pharmaceutical Research Laboratories, Toray Industries, Kamakura-city, Kanagawa, Japan.
Patients with acute- or lymphoma-type adult T-cell leukemia (ATL) have a poor outcome because of the intrinsic drug resistance to chemotherapy. Protection from apoptosis is a common feature involved in multidrug-resistance of ATL. IAP (inhibitor of apoptosis) family proteins inhibit apoptosis induced by a variety of stimuli. In this study, we investigated the expression of IAP family members (survivin, cIAP1, cIAP2, and XIAP) in the primary leukemic cells from patients with ATL. We found that survivin was overexpressed in ATL, especially in acute-type ATL. Sodium arsenite was shown to down-regulate the expression of survivin at both the protein and RNA levels in a time- and dose-dependent manner, thus inhibiting cell growth, inducing apoptosis, and enhancing the caspase-3 activity in ATL cells. Nuclear factor-
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||